| How will bioinformatics influence metabolic engineering? |
J.S. Edwards; B.Ø. Palsson |
1998 |
| Cell cycle dependence of retroviral transduction: An issue of overlapping time scales. |
S.T. Andreadis; A.O. Fuller; B.Ø. Palsson |
1998 |
| What lies beyond bioinformatics? |
B.Ø. Palsson |
1997 |
| Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis. |
M.R. Koller; I. Manchel; B.Ø. Palsson |
1997 |
| Coupled effects of polybrene and calf serum on the efficiency of retroviral transduction and the stability of retroviral vectors. |
S.T. Andreadis; B.Ø. Palsson |
1997 |
| Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. |
S.T. Andreadis; D.A. Brott; A.O. Fuller; B.Ø. Palsson |
1997 |
| Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion. |
K. Francis; B.Ø. Palsson |
1997 |
| Determination of specific oxygen uptake rates in human hematopoietic cultures and implications for bioreactor design. |
C.A. Peng; B.Ø. Palsson |
1996 |
| Cell growth and differentiation on feeder layers is predicted to be influenced by bioreactor geometry. |
C.A. Peng; B.Ø. Palsson |
1996 |
| Different measures of human hematopoietic cell culture performance are optimized under vastly different conditions. |
M.R. Koller; I. Manchel; M.A. Palsson; R.J. Maher; B.Ø. Palsson |
1996 |
| Membrane adsorption characteristics determine the kinetics of flow-through transductions. |
A.S. Chuck; B.Ø. Palsson |
1996 |
| Retroviral infection is limited by Brownian motion. |
A.S. Chuck; M.F. Clarke; B.Ø. Palsson |
1996 |
| Kinetics of retrovirus mediated gene transfer: the importance of intracellular half-life of retroviruses. |
S.T. Andreadis; B.Ø. Palsson |
1996 |
| flt-3 ligand is more potent than c-kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion. |
M.R. Koller; M. Oxender; D.A. Brott; B.Ø. Palsson |
1996 |
| Unilineage model of hematopoiesis predicts self-renewal of stem and progenitor cells based on ex vivo growth data. |
C.A. Peng; M.R. Koller; B.Ø. Palsson |
1996 |
| Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors. |
M.R. Koller; I. Manchel; D.A. Brott; D.A. Brott |
1996 |
| Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid. |
C.E. Rogers; M.S. Bradley; B.Ø. Palsson; M.R. Koller |
1996 |
| Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. |
A.S. Chuck; B.Ø. Palsson |
1996 |
| In vitro expansion of hematopoietic cells for clinical application. |
S.G. Emerson; B.Ø. Palsson; M.F. Clarke; S.M. Silver; P.T. Adams; M.R. Koller; G. Van Zant; S. Rummel; R.D. Armstrong; J. Maluta |
1995 |
| Parametric sensitivity of stoichiometric flux balance models applied to wild-type Escherichia coli metabolism. |
A. Varma; B.Ø. Palsson |
1995 |
| Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. |
M.R. Koller; I. Manchel; B.S. Newsom; M.A. Palsson; B.Ø. Palsson |
1995 |
| Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. |
M.R. Koller; M.A. Palsson; I. Manchel; B.Ø. Palsson |
1995 |
| Growth factor consumption and production in perfusion cultures of human bone marrow correlate with specific cell production. |
M.R. Koller; M.S. Bradley; B.Ø. Palsson |
1995 |
| Retroviral-mediated gene transfer in human bone marrow cells growth in continuous perfusion culture vessels. |
P.G. Eipers; J.C. Krauss; B.Ø. Palsson; S.G. Emerson; R.F. Todd; M.F. Clarke |
1995 |
| Enhanced specific antibody productivity of calcium alginate-entrapped hybridoma is cell line-specific. |
G.M. Lee; S.J. Kim; B.Ø. Palsson |
1994 |
| Predictions for oxygen supply control to enhance population stability of engineered production strains. |
A. Varma; B.Ø. Palsson |
1994 |
| Preface. Tissue engineering and cell therapies. |
J.A. Hubbell; B.Ø. Palsson; E.T. Papoutsakis |
1994 |
| Preface: Tissue engineering and cell therapies: II. |
J.A. Hubbell; B.Ø. Palsson; E.T. Papoutsakis |
1994 |
| Microencapsulated human bone marrow cultures: a potential culture system for the clonal outgrowth of hematopoietic progenitor cells. |
M.G. Levee; G.M. Lee; S.H. Paek; B.Ø. Palsson |
1994 |
| Frequent harvesting from perfused bone marrow cultures results in increased overall cell and progenitor expansion. |
D.J. Oh; M.R. Koller; B.Ø. Palsson |
1994 |